4.4 Article

Corticosteroids for the treatment of respiratory infection by Mycoplasma pneumoniae in children: A cost-utility analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Health Care Sciences & Services

Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia

Oscar Espinosa et al.

Summary: This study examined the healthcare system of the middle-income country Colombia, estimating the cost-effectiveness threshold and exploring the variation of health expenditures and outcomes. The threshold was found to be around one times the GDP per capita, providing valuable insights for decision-making in a managed healthcare system.

HEALTH POLICY AND PLANNING (2022)

Review Pharmacology & Pharmacy

Corticosteroids in Community-Acquired Pneumonia: A Review of Current Literature

Lindsay K. Harris et al.

Summary: Studies suggest that corticosteroids are relatively beneficial and safe in patients with CAP, with the greatest benefit observed in severe CAP. Routine use of corticosteroids is not recommended by clinical practice guidelines except in cases of CAP and refractory septic shock. Further research is needed to better define the ideal role of corticosteroids in CAP.

JOURNAL OF PHARMACY TECHNOLOGY (2021)

Article Critical Care Medicine

The Cost-Effectiveness of Corticosteroids for the Treatment of Community-Acquired Pneumonia

Elina Eleftheria Pliakos et al.

Review Medicine, General & Internal

Antiinflammatory action of glucocorticoids - New mechanisms for old drugs

T Rhen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)